AIMTF
Aimfinity Investment Corp. I7.07
-4.03-36.3%
Oct 3, 11:25:57 AM EDT
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
-P/E (TTM)
-Basic EPS (TTM)
-Dividend Yield
0%Recent Filings
8-K
Fifth SPAC extension funded
Aimfinity Investment Corp. I issued a $500 unsecured promissory note to sponsor manager I-Fa Chang on February 28, 2026, funding the fifth monthly trust deposit to extend its business combination deadline to March 28, 2026—the latest of nine allowed under its charter. The note converts to PubCo shares at $10.00 upon Docter merger close. Extensions buy time. Closing risks persist.
8-K
SPAC extends deadline again
Aimfinity Investment Corp. I issued a $500 unsecured promissory note to sponsor designee I-Fa Chang on January 28, 2026, funding the fourth monthly trust deposit to extend its business combination deadline from January 28 to February 28, 2026. The note converts to PubCo shares at $10.00 upon Docter merger closing. Fourth of nine extensions. Risks include deal failure.
8-K
Third SPAC extension funded
Aimfinity Investment Corp. I issued a $500 unsecured promissory note to sponsor designee I-Fa Chang on December 28, 2025, funding the third monthly trust extension to January 28, 2026. This buys time for the pending Docter business combination, with the note converting to PubCo shares at $10.00 upon close. Extensions run through July 2026. Deal risks persist.
10-Q
Q3 FY2025 results
Aimfinity trimmed formation costs 77% y/y to $103,316 in Q3 ended September 30, 2025, swinging to a $42k net profit on $146k Trust interest—yet redeemable shares plunged 64% q/q to 1.1M after $24M outflows, leaving $14.3M in Trust at $12.80/share. Operating cash burn eased to $365k YTD (derived). Related-party debt sits at $1.9M working capital plus $335k extension loans, with $3.5k cash outside Trust amid going concern warnings. Converted $1.5M debt to 150k private units in April. Merger with Docter awaits by December 28 deadline. Sponsor extensions bought time. Heavy redemptions signal shareholder skepticism.
8-K
SPAC extends Docter deal deadline
Aimfinity Investment Corp. I issued a $500 unsecured promissory note to sponsor manager I-Fa Chang on November 28, 2025, funding the first monthly trust deposit to extend its Docter business combination deadline from November 28 to December 28, 2025—one of nine possible extensions to July 2026. The note converts to PubCo shares at $10.00 upon closing. Deadline bought.
AACI
Armada Acquisition Corp. II
10.29-0.01
AFJK
Aimei Health Technology Co., Lt
26.96-3.55
APXIF
APx Acquisition Corp. I
11.99+0.00
CCTSF
Cactus Acquisition Corp. 1 Limi
11.79+0.00
CSTAF
Constellation Acquisition Corp
11.52+0.00
HAIAF
Healthcare AI Acquisition Corp.
12.74+0.00
IMAQ
International Media Acquisition
9.72+0.00
IVAUF
Investcorp AI Acquisition Corp.
13.99+0.00
SIMA
SIM Acquisition Corp. I
10.57+0.01
VMCAF
Valuence Merger Corp. I
12.31+0.00